Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats

RationaleThe stop-signal paradigm measures the ability to stop a motor response after its execution has been initiated. Impairments in inhibiting inappropriate behavior and prolonged stop-signal reaction times (SSRTs) are characteristic of several psychiatric disorders, most notably attention deficit/hyperactivity disorder. While there is relative consensus regarding the anatomical substrates of behavioral inhibition, the neurochemical imbalance responsible for the deficits in stopping displayed by impulsive individuals is still a matter of debate.ObjectiveThe aim of this study was to investigate the effects of manipulating brain monoamine levels on stop task parameters.MethodsLister-hooded rats were trained on the rodent version of the stop-signal task and administered different monoamine transporter inhibitors: citalopram, which selectively blocks the serotonin transporter; atomoxetine, which selectively blocks the noradrenaline transporter; and GBR-12909, which selectively blocks the dopamine transporter (DAT), and the alpha-2 adrenergic agonist guanfacine.ResultsAtomoxetine speeded SSRT and increased accuracy for go-trials. Citalopram slowed go reaction time and decreased go accuracy at the highest dose (1 mg/kg). GBR-12909 speeded go reaction time and impaired both go and stop accuracy. Guanfacine negatively modulated all principal stop and go measures at the highest dose used (0.3 mg/kg).ConclusionsThe results suggest that atomoxetine exerts its beneficial effects on SSRT via its action on noradrenaline re-uptake, as the specific DAT blocker GBR-12909 and serotonin reuptake blockade had only minor effects on SSRT. The speeding of the go reaction time by dopamine reuptake blockade is consistent with the hypothesis that the hypothetical stop and go processes are modulated by distinct monoaminergic systems.

[1]  K. Rubia.  The dynamic approach to neurodevelopmental psychiatric disorders: use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia , 2002, Behavioural Brain Research.

[2]  H. de Wit,et al.  Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. , 2000, Behavioral Neuroscience.

[3]  T. Robbins,et al.  Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. , 2003, Behavioral neuroscience.

[4]  T. Robbins,et al.  Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat , 2008, Neuropsychopharmacology.

[5]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[6]  Tong Xu,et al.  The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD) , 2006, Behavioral and Brain Functions.

[7]  T. Robbins,et al.  Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity , 2005, Psychopharmacology.

[8]  P. Goldman-Rakic,et al.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  Jennifer M. Glass,et al.  Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene , 2006, Psychiatric genetics.

[10]  Jaap Oosterlaan,et al.  Inhibitory dysfunction in hyperactive boys , 1998, Behavioural Brain Research.

[11]  L. Iversen,et al.  Neurotransmitter transporters and their impact on the development of psychopharmacology , 2006, British journal of pharmacology.

[12]  V. Libri,et al.  Evidence that locus coeruleus is the site where clonidine and drugs acting at α1‐ and α2‐adrenoceptors affect sleep and arousal mechanisms , 1987 .

[13]  M. Zigmond,et al.  Local Influence of Endogenous Norepinephrine on Extracellular Dopamine in Rat Medial Prefrontal Cortex , 1995, Journal of neurochemistry.

[14]  L. Descarries,et al.  Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain , 1997, Synapse.

[15]  C. M. Bradshaw,et al.  Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers , 2005, Psychopharmacology.

[16]  T. Robbins,et al.  Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans , 2006, Science.

[17]  G. Chiara,et al.  Contribution of Blockade of the Noradrenaline Carrier to the Increase of Extracellular Dopamine in the Rat Prefrontal Cortex by Amphetamine and Cocaine , 1997, European Journal of Neuroscience.

[18]  K. Perry,et al.  Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine , 2006, Molecular Psychiatry.

[19]  T. Robbins,et al.  Chemical neuromodulation of frontal-executive functions in humans and other animals , 2000, Experimental Brain Research.

[20]  T. Robbins,et al.  Serotonin Depletion Impairs Waiting but not Stop-Signal Reaction Time in Rats: Implications for Theories of the Role of 5-HT in Behavioral Inhibition , 2009, Neuropsychopharmacology.

[21]  Ulrich Müller,et al.  Lack of effects of guanfacine on executive and memory functions in healthy male volunteers , 2005, Psychopharmacology.

[22]  T. Robbins,et al.  5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion , 2004, Psychopharmacology.

[23]  JaneR . Taylor,et al.  Supranormal Stimulation of D1 Dopamine Receptors in the Rodent Prefrontal Cortex Impairs Spatial Working Memory Performance , 1997, The Journal of Neuroscience.

[24]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[25]  D. Heal,et al.  New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD , 2008, Pharmacology Biochemistry and Behavior.

[26]  H. Engeland,et al.  Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder , 2003, Behavioural Brain Research.

[27]  A. Arnsten,et al.  The α-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys , 1998, Psychopharmacology.

[28]  H. de Wit,et al.  Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. , 2000, Behavioral neuroscience.

[29]  T. Robbins,et al.  Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans , 2003, Nature Neuroscience.

[30]  B. Pitt.  Psychopharmacology , 1968, Mental Health.

[31]  E. Eriksson,et al.  Effects of α2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  Andrew P. Smith,et al.  Noradrenaline and attention lapses , 1996, Nature.

[33]  P. Soubrié,et al.  [Serotonergic neurons and behavior]. , 1986, Journal de pharmacologie.

[34]  D. C. Howell.  Statistical Methods for Psychology , 1987 .

[35]  Trevor W. Robbins,et al.  Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol , 2007, Psychopharmacology.

[36]  J S Fowler,et al.  Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. , 1997, The American journal of psychiatry.

[37]  Claudia Balducci,et al.  Dissociable Contribution of 5-HT1A and 5-HT2A Receptors in the Medial Prefrontal Cortex to Different Aspects of Executive Control such as Impulsivity and Compulsive Perseveration in Rats , 2006, Neuropsychopharmacology.

[38]  E. Richelson,et al.  Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. , 1984, European journal of pharmacology.

[39]  J. Evenden.  Varieties of impulsivity , 1999, Psychopharmacology.

[40]  Jennifer T Coull,et al.  Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans , 2004, NeuroImage.

[41]  J. Swanson,et al.  Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. , 2004, The American journal of psychiatry.

[42]  F. Marshall,et al.  Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast , 2006, Psychopharmacology.

[43]  J. Buitelaar,et al.  Does Methylphenidate Improve Inhibition and Other Cognitive Abilities in Adults with Childhood-Onset ADHD? , 2005, Journal of clinical and experimental neuropsychology.

[44]  Barry J. Everitt,et al.  Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.

[45]  P F Renshaw,et al.  Using MRI to examine brain-behavior relationships in males with attention deficit disorder with hyperactivity. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  A. Arnsten,et al.  Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats , 2000, Pharmacology Biochemistry and Behavior.

[47]  Anne W. Schmidt,et al.  Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex. , 2007, European journal of pharmacology.

[48]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[49]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[50]  T. Robbins.  Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[51]  G. Logan,et al.  On the ability to inhibit simple and choice reaction time responses: a model and a method. , 1984, Journal of experimental psychology. Human perception and performance.

[52]  J. Rapoport,et al.  Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.

[53]  G. Gessa,et al.  Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex , 2004, Journal of neurochemistry.

[54]  G. Logan.  On the ability to inhibit thought and action , 1984 .

[55]  A. Deutch.  The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[56]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[57]  T. Robbins,et al.  Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination , 1999, Behavioural Brain Research.

[58]  G D Logan,et al.  Response inhibition in AD/HD, CD, comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies with the stop task. , 1998, Journal of child psychology and psychiatry, and allied disciplines.

[59]  R. Barkley.  Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. , 1997, Psychological bulletin.

[60]  V. Libri,et al.  Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. , 1987, British journal of pharmacology.

[61]  M. Hamon,et al.  Neurotransmitter transporters in the central nervous system. , 1999, Pharmacological reviews.

[62]  L. Pozzi,et al.  Evidence that Extracellular Concentrations of Dopamine Are Regulated by Noradrenergic Neurons in the Frontal Cortex of Rats , 1994, Journal of neurochemistry.

[63]  J. Russo,et al.  Comparing Guanfacine and Dextroamphetamine for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder , 2001, Journal of clinical psychopharmacology.

[64]  J. David Jentsch,et al.  Poor response inhibition: At the nexus between substance abuse and attention deficit/hyperactivity disorder , 2009, Neuroscience & Biobehavioral Reviews.

[65]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[66]  A. Arnsten,et al.  Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions , 2004, Biological Psychiatry.

[67]  G H Glover,et al.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Robbins,et al.  Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. , 2008, Cerebral cortex.

[69]  E. Barratt,et al.  Psychiatric aspects of impulsivity. , 2001, The American journal of psychiatry.

[70]  S. Sesack,et al.  Cellular and subcellular localization of the dopamine transporter in rat cortex. , 1998, Advances in pharmacology.

[71]  Gordon D. Logan,et al.  Effects of methylphenidate on inhibitory control in hyperactive children , 1989, Journal of abnormal child psychology.

[72]  T. Carr,et al.  Inhibitory Processes in Attention, Memory and Language , 1994 .

[73]  R. Schultz,et al.  A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. , 2001, The American journal of psychiatry.